[1]
Muhammad Afnan, Hamza Shakeel, Ghulam Mustafa, Waseem Akram, and Talib Husain, “Formulation, development and optimization of ofloxacin FDDS sustained release for UTI and H. pylori”, JCP, vol. 8, no. 1, pp. 1–8, Jun. 2024.